
Foundery Biosciences is a pioneering immunotherapy venture studio fund that accelerates early-stage R&D and builds drug discovery programs to address diseases related to autoimmunity, inflammation, and immuno-oncology. By leveraging deep immune phenotyping datasets and AI, the company creates multiple startups focused on developing and commercializing immunotherapeutics. Their unique approach combines academic collaborations with advanced technology platforms, aiming to transform scientific discoveries into groundbreaking medicines while ensuring capital efficiency and strong returns for investors.

Foundery Biosciences is a pioneering immunotherapy venture studio fund that accelerates early-stage R&D and builds drug discovery programs to address diseases related to autoimmunity, inflammation, and immuno-oncology. By leveraging deep immune phenotyping datasets and AI, the company creates multiple startups focused on developing and commercializing immunotherapeutics. Their unique approach combines academic collaborations with advanced technology platforms, aiming to transform scientific discoveries into groundbreaking medicines while ensuring capital efficiency and strong returns for investors.